Phase 1B study of enzalutamide (ENZA) with or without sorafenib (SORA) in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Harding, J. J.; Kelley, R. K.; Tan, B. R.; Iobst, E.; Boussayoud, C.; Muenkel, K. E.; Do, R. K. G.; Chou, J. F.; Capanu, M.; Ruiz, C.; Lee, M. R.; Wilton, J.; Iyer, R. V.; Abou-Alfa, G. K. |
| Abstract Title: | Phase 1B study of enzalutamide (ENZA) with or without sorafenib (SORA) in patients (pts) with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 222s |
| Language: | English |
| ACCESSION: | WOS:000442916001659 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4083 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4083 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
